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502 CORRESPONDENCE 
Bronchiolitis obliterans organizing pneumonia 
in a BMT patient receiving FK506 
Sir. 
Thirman et al. I have reported a patient who twice 
~nderwent allogeneic BMT and developed bronchioli-
t~s obliterans organizing pneumonia (BOOP) each 
time. once clearly in association with chronic GVHD. 
Based on their review of the literature. thev concluded 
that BOOP may be a manifestation of chronic GVHD. 
alb~it infrequently. Our recent experience with a 
patient who developed BOOP in the absence of chronic 
GVHD suggests otherwise. 
A 23-year-old female received high dose thiotepa. 
CY. total body irradiation and a one-antigen mis-
matched marrow from her mother as treatment for 
ALL in second relapse. The marrow was partially 
depleted for CD3+ cells. CY A. methylprednisolone 
(MP) and anti-CDS ricin A chain immunoconjugate 
Euw-CKo~F were given post-transplant as GVHD pro-
phylaXIS. - The granulocytes exceeded 0.5 x 109/I on 
day 10 after transplantation. XZ-CD5 and MP were 
discontinued on day 20 when capillary leak syndrome 
occurred. and the symptoms resolved with conservative 
management. 
Grade II acute GVHD involving the skin occurred 
on day 34 and responded rapidly to treatment with high 
dose MP. She presented with hemolytic-uremic syn-
drome (HUS) manifested as microangiopathic hemo-
lytic anemia and renal insufficiency on dav 44. CY A 
was discontinued. and treatment consisted of high dose 
MP and plasma exchange. By day 86. the HUS had 
largely. resolved. and a marrow biopsy showed no 
leukemia. Evaluation showed no evidence of acute or 
chronic GVHD. but she had developed moderatelv 
severe muscle weakness. hypertension. edema and 
hyperglycemia as a result of prolonged use of high dose 
MP. On day 88 she was started on FKS06 for GVHD 
prophylaxis using a regimen reported previously. 3 and 
MP was tapered rapidly to 20 mg daily with resolution 
of the steroid-related problems and no HVS. 
She did well until day 140 when she presented with a 
2-day history of a non-productive cough without fever. 
Physical examination showed no evidence of chronic 
GVHD. and the liver enzymes were normal. A chest 
~-ray s~owe~ patchy infiltrates. Because of the suspi-
cIon of mfectlOn or EBV-lymphoproliferative disease. 
FK506 was discontinued. Culture of an oral lesion grew 
HSV. but cultures of bronchoalveolar lavCl.ge fluid were 
negative for bacteria. fungus. virus and opportunistic 
agents. The infiltrates progressed. and the patient 
required intubation despite administration of standard 
broad-spectrum antibiotics. Subsequent treatment con-
sisted of vancomycin. aztreonam. amphotericin. trime-
thoprim/sulfamethoxazole. erythromycin. ganciclovir. 
iv imf!1unoglobulin. isoniazid. rifampin. doxycycline. 
and hIgh dose MP. An open lung biopsy on day 145 
showed BOOP. The biopsy culture grew Veillonella. 
but this was considered to be a contaminant. as a 
bacteri~1 process was not seen on the biopsy. Despite 
aggressive management. the patient died from respira-
tory in~ufficiency on day 160. An autopsy revealed 
BOOP 10 the lungs as was found in the biopsy. Chronic 
GVHD was not found in any organ at autopsy. 
This patient is the second well-documented case of 
BOOP after allogeneic BMT. Our patient differs from 
that reported by Thirman et al. in that she had no 
evidence of chronic GVHD on clinical evaluation or at 
autopsy. It is possible that BOOP is a manifestation of 
chronic GVHD but other clinical disease in our patient 
was prevented by the use of FKS06. Indeed. \0 a series 
of patients receiving FKS06 for treatment of chronic 
GVHD. pulmonary involvement was least responsive 
to therapy . .1 Further experience will be required to 
characterize BOOP in the allogeneic BMT population 
completely. but our case suggests that BOOP should be 
!nc.luded in the. differential diagnosis of pulmonary 
mflltrates even m the absence of other manifestations 
of chronic GVHD. 
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